Modernistic and Emerging Developments of Nanotechnology in Glioblastoma-Targeted Theranostic Applications

Buddolla Anantha Lakshmi1, Young-Joon Kim1

  • 1Department of Electronic Engineering, Gachon University, Seongnam-Daero 1342, Incheon 13120, Korea.

Insights

Nanotechnology offers advanced theranostics for glioblastoma, overcoming blood-brain barrier challenges. These nanomaterials enable combined diagnosis and therapy, improving glioblastoma treatment strategies.

Area of Science:

  • Oncology
  • Nanomedicine
  • Biotechnology

Background:

  • Glioblastoma is an aggressive brain tumor characterized by rapid cell proliferation and infiltration.
  • Current treatments like chemotherapy and radiotherapy are limited by the blood-brain barrier's impermeability.
  • There is a critical need for innovative therapeutic strategies to effectively manage glioblastoma.

Purpose of the Study:

  • To review recent advancements in nanotechnology for glioblastoma diagnosis and therapy.
  • To highlight the potential of multifunctional nanomaterials in overcoming treatment challenges.
  • To discuss the integration of thermal and magnetic therapy approaches using nanotechnology.

Main Methods:

  • Review of current literature on nanotechnology applications in glioblastoma research.
  • Analysis of nanomaterial properties relevant to drug delivery and imaging.
  • Discussion of theranostic approaches combining diagnosis and treatment.

Main Results:

  • Nanotechnology enables the development of multifunctional theranostics for glioblastoma.
  • Nanomaterials offer enhanced features like real-time tracking, tissue penetration, and drug-loading capacity.
  • Near-infrared (NIR) and photoacoustic (PA) imaging modalities are leveraged by nanomaterials.

Conclusions:

  • Nanotechnology-based theranostics show significant promise for improved glioblastoma diagnosis and treatment.
  • Multifunctional nanomaterials offer specificity, tunability, and biodegradability for effective therapeutic strategies.
  • Further clinical investigation of nanotech-driven theranostics is warranted for glioblastoma management.